Bleeding disorders panel

The Bleeding Disorders Panel (NGS) evaluates a comprehensive set of genes involved in blood coagulation, platelet function, and vascular integrity. Using next-generation sequencing technology, the test detects pathogenic variants responsible for inherited bleeding disorders, enabling accurate diagnosis and improved clinical management.

This panel is useful for patients with unexplained bleeding symptoms, prolonged bleeding time, easy bruising, or a family history of bleeding disorders. It supports differentiation between various inherited conditions such as hemophilia, von Willebrand disease-related genes, and rare platelet function disorders.

The results assist clinicians in confirming diagnosis, guiding treatment strategies, and providing genetic counseling for affected families.